Crystals (Basel) 11:1092
Its the foundation upon which safe and effective research is built
By systematically addressing these microenvironmental dynamics and physical translational hurdles, this review aims to provide a refined conceptual framework and practical engineering solutions for the next generation of ferroptosis-targeted ocular therapies
Results depend on diet, training, sleep, and starting body composition
Retatrutide is at the Phase 3 stage, and the cagrilintide-plus-semaglutide combination CagriSema was reported to have a New Drug Application under FDA review, but a filing under review is not an approval
Meanwhile, key challenges, such as scalable standardization, stability, and potential cytotoxicity, continue to be actively addressed